{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:21:09Z","timestamp":1786933269577,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-Sen University","doi-asserted-by":"publisher","award":["2023002"],"award-info":[{"award-number":["2023002"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471068"],"award-info":[{"award-number":["82471068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajo.2026.01.030","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:19:57Z","timestamp":1769559597000},"page":"16-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IgG4-Positive Ocular Adnexal Extranodal Marginal Zone Lymphoma as an Aggressive Clinical Subtype: Evidence From a 377-Patient Cohort"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6751-6577","authenticated-orcid":false,"given":"Hetian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-5860","authenticated-orcid":false,"given":"Weifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-0517","authenticated-orcid":false,"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2026.01.030_bib0001","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ajo.2026.01.030_bib0002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bjophthalmol-2019-315637","article-title":"Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017","volume":"105","author":"Holm","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11882-015-0580-7","article-title":"IgG4 Characteristics and functions in cancer immunity","volume":"16","author":"Crescioli","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.ajo.2026.01.030_bib0004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/pin.13251","article-title":"Clinical characteristics and outcomes of IgG4-positive marginal zone lymphoma: systematic scoping review","volume":"72","author":"Nishimura","year":"2022","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.ajo.2026.01.030_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14397595.2016.1216733","article-title":"Ocular adnexal marginal zone lymphoma arising in a patient with IgG4-related ophthalmic disease","volume":"29","author":"Nishida","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajo.2026.01.030_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/srep13539","article-title":"A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease","volume":"5","author":"Ohno","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2026.01.030_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2559.2011.04089.x","article-title":"Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions","volume":"60","author":"Go","year":"2012","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ajo.2026.01.030_bib0008","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/01676830.2021.1962365","article-title":"Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease","volume":"41","author":"Yoon","year":"2022","journal-title":"Orbit"},{"key":"10.1016\/j.ajo.2026.01.030_bib0009","article-title":"Clinical features and prognoses of IgG4-positive and IgG4-negative lacrimal lymphomas","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.ajo.2026.01.030_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145017","article-title":"The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer","volume":"21","author":"Bianchini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2026.01.030_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27712","article-title":"PET\/CT in the staging and treatment response assessment of patients with extranodal marginal zone lymphoma","author":"Alderuccio","year":"202510081295","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.ajo.2026.01.030_bib0012","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5858\/133.8.1262","article-title":"A TNM-based clinical staging system of ocular adnexal lymphomas","volume":"133","author":"Coupland","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.ajo.2026.01.030_bib0013","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye (Lond)"},{"issue":"20","key":"10.1016\/j.ajo.2026.01.030_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17203392","article-title":"The central anatomical question: treatment of lymphoma within border-zone anatomical sites adjacent to the central nervous system","volume":"17","author":"Marsters","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100441","article-title":"Fifth edition of the World Health Classification of tumors of the hematopoietic and lymphoid tissues: B-cell neoplasms","volume":"37","author":"Medeiros","year":"2024","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.ajo.2026.01.030_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100512","article-title":"Fifth edition of the World Health Organization Classification of tumors of the hematopoietic and lymphoid tissues: mature T-cell, NK-cell, and stroma-derived neoplasms of lymphoid tissues","volume":"37","author":"Miranda","year":"2024","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ajo.2026.01.030_bib0017","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th Edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0018","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41375-024-02227-5","article-title":"Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma","volume":"38","author":"Gao","year":"2024","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0019","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12185-008-0170-8","article-title":"IgG4-producing marginal zone B-cell lymphoma","volume":"88","author":"Sato","year":"2008","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.ajo.2026.01.030_bib0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bjophthalmol-2020-315875","article-title":"Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM classification","volume":"105","author":"Kwon","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.01.030_bib0021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bjophthalmol-2019-314008","article-title":"International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma","volume":"104","author":"Hinds\u00f8","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.01.030_bib0022","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2214\/ajr.168.3.9057538","article-title":"Imaging the temporal fossa","volume":"168","author":"Swanson","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0023","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13244-016-0498-1","article-title":"The pterygopalatine fossa: imaging anatomy, communications, and pathology revisited","volume":"7","author":"Tashi","year":"2016","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12880-021-00556-w","article-title":"Primary marginal zone B-cell lymphoma of the cavernous sinus: a case report and review of the literature","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Med Imaging"},{"issue":"6","key":"10.1016\/j.ajo.2026.01.030_bib0025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209767","article-title":"Teaching video NeuroImage: isolated presentation of cavernous sinus syndrome from CNS lymphoma","volume":"103","author":"Itoh","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","article-title":"Prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future","volume":"34","author":"Diagnostic","year":"2023","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41408-024-01162-z","article-title":"Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study","volume":"14","author":"Grover","year":"2024","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.ajo.2026.01.030_bib0028","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/bjo-2022-321656","article-title":"Predicting the risk of distant and local recurrence for patients with ocular adnexal extranodal marginal zone lymphoma: a matched case-control study","volume":"107","author":"Shi","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0029","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bjophthalmol-2017-310741","article-title":"Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa","volume":"102","author":"Nam","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ajh.26591","article-title":"Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma","volume":"98","author":"Saul","year":"2023","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ajo.2026.01.030_bib0031","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2016-05-714584","article-title":"Long-term course of patients with primary ocular adnexal malt lymphoma: a large single-institution cohort study","volume":"129","author":"Desai","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ajo.2026.01.030_bib0032","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ophtha.2008.02.004","article-title":"Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases","volume":"115","author":"Demirci","year":"2008","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.01.030_bib0033","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2021-320466","article-title":"Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study","volume":"107","author":"Vest","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.01.030_bib0034","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jamaneurol.2017.2545","article-title":"Optic nerve infiltration in primary central nervous system lymphoma","volume":"74","author":"Ahle","year":"2017","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ajo.2026.01.030_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009034","article-title":"Fc-Fc interactions and immune inhibitory effects of IgG4: implications for anti-PD-1 immunotherapies","volume":"12","author":"Zhang","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.ajo.2026.01.030_bib0036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13635","article-title":"IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance","volume":"74","author":"Bianchini","year":"2019","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.ajo.2026.01.030_bib0037","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2026.01.030_bib0038","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00428-016-1914-0","article-title":"A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis","volume":"468","author":"Miyatani","year":"2016","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0039","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajo.2026.01.030_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100885","article-title":"Non-specific orbital inflammation: current understanding and unmet needs","volume":"81","author":"Lee","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2026.01.030_bib0041","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.survophthal.2021.05.011","article-title":"Non-infectious dacryoadenitis","volume":"67","author":"Singh","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","article-title":"Treatments for ocular adnexal lymphoma: a report by the American Academy of Ophthalmology","volume":"125","author":"Yen","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.01.030_bib0043","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ajo.2026.01.030_bib0044","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-022-01257-9","article-title":"Targeting Fc\u03b3RIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/j.ajo.2026.01.030_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","article-title":"PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas","volume":"14","author":"Goodman","year":"2017","journal-title":"Nat Rev Clin Oncol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:26:04Z","timestamp":1782116764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S0002939426000449"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.01.030","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-Positive Ocular Adnexal Extranodal Marginal Zone Lymphoma as an Aggressive Clinical Subtype: Evidence From a 377-Patient Cohort","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}